Cumberland pharmaceuticals reports 17% revenue growth for full year 2022

2022 highlights include its acquisition of sancuso ® and move to new headquarters nashville, tenn. , march 7, 2023 /prnewswire/ -- cumberland pharmaceuticals inc. (nasdaq: cpix), a specialty pharmaceutical company today announced full year 2022 financial results and provided a company update.

CPIX Ratings Summary

CPIX Quant Ranking